These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9689295)

  • 1. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration.
    Benfeldt E; Groth L
    Acta Derm Venereol; 1998 Jul; 78(4):274-8. PubMed ID: 9689295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous microdialysis. Methodology and validation.
    Groth L
    Acta Derm Venereol Suppl (Stockh); 1996; 197():1-61. PubMed ID: 8982432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin.
    Degim IT; Hadgraft J; Houghton E; Teale P
    J Small Anim Pract; 1999 Nov; 40(11):515-8. PubMed ID: 10649594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function.
    Benfeldt E; Serup J
    Arch Dermatol Res; 1999 Sep; 291(9):517-26. PubMed ID: 10541883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probe depth matters in dermal microdialysis sampling of benzoic acid after topical application: an ex vivo study in human skin.
    Holmgaard R; Benfeldt E; Bangsgaard N; Sorensen JA; Brosen K; Nielsen F; Nielsen JB
    Skin Pharmacol Physiol; 2012; 25(1):9-16. PubMed ID: 21849814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis.
    Cobb MA; Edwards HJ; Jagger TD; Marshall J; Bowker KE
    Vet J; 2005 Mar; 169(2):276-80. PubMed ID: 15727921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products.
    Simonsen L; Fullerton A
    Skin Pharmacol Physiol; 2007; 20(5):230-6. PubMed ID: 17587887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
    Kubota K; Lo ES; Huttinot G; Andersen PH; Maibach HI
    Br J Clin Pharmacol; 1994 Jan; 37(1):86-8. PubMed ID: 8148226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis.
    Morgan CJ; Renwick AG; Friedmann PS
    Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid.
    Frosini SM; Bond R; Loeffler A; Larner J
    BMC Vet Res; 2017 Nov; 13(1):345. PubMed ID: 29162115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function.
    Benfeldt E; Serup J; Menné T
    Br J Dermatol; 1999 Apr; 140(4):739-48. PubMed ID: 10233334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel stability-indicating HPLC method for the simultaneous assay of betamethasone-17-valerate, fusidic acid, potassium sorbate, methylparaben and propylparaben in a topical cream preparation.
    Byrne J; Velasco-Torrijos T; Reinhardt R
    J Pharm Biomed Anal; 2014 Aug; 96():111-7. PubMed ID: 24731970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin.
    Jungersted JM; Høgh JK; Hellegren LI; Jemec GB; Agner T
    Acta Derm Venereol; 2011 May; 91(3):290-4. PubMed ID: 21365172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusidic acid betamethasone lipid cream.
    Girolomoni G; Mattina R; Manfredini S; Vertuani S; Fabrizi G
    Int J Clin Pract; 2016 May; 70 Suppl 184():4-13. PubMed ID: 27121235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1993 Oct; 82(10):1039-45. PubMed ID: 8254489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusidic acid in dermatology: an updated review.
    Schöfer H; Simonsen L
    Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusidic acid-betamethasone combination in infected eczema: an open, randomized comparison with gentamicin-betamethasone combination.
    Strategos J
    Pharmatherapeutica; 1986; 4(9):601-6. PubMed ID: 3763654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamic determination of sinomenine in skin by microdialysis].
    Ling JJ; Xie B; Wang Y; Zhou LL
    Zhong Yao Cai; 2008 Jul; 31(7):1062-5. PubMed ID: 18973024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.